Clinical trials
Not yet recruiting Phase 1/2 Endometrial Neoplasms trials
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
8 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2024 | 1 |
| 2025 | 1 |
| 2026 | 6 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Not yet recruiting | 8 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Advenchen Pharmaceuticals, LLC. | 2 |
| BioMimetix JV, LLC | 1 |
| GlaxoSmithKline | 1 |
| LG Chem | 1 |
| NovaOnco Therapeutics Co., Ltd. | 1 |
| Qilu Pharmaceutical Co., Ltd. | 1 |
| Tubulis GmbH | 1 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Endometrial Neoplasms | 8 |
| Ovarian Neoplasms | 5 |
| Breast Neoplasms | 3 |
| Carcinoma, Non-Small-Cell Lung | 2 |
| Sarcoma | 2 |
| Colorectal Neoplasms | 1 |
| Esophageal Neoplasms | 1 |
| Glioblastoma | 1 |
| Head and Neck Neoplasms | 1 |
| Neoplasm Metastasis | 1 |
Trials
Showing 1 to 8 of 8. Each trial links to its page on Pharma Observatory.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.